Cellectar Biosciences, Inc. Operating Cash Flow
Cellectar Biosciences, Inc. (CLRB) reported Operating Cash Flow of -$10.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- Cellectar Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$6.01M.
- Cellectar Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.85M.
- Cellectar Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.34M.
- Cellectar Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.28M.
- Cellectar Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$23.12M.
- Cellectar Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$47.58M.
- Cellectar Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$32.38M.
- Cellectar Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$25.22M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 104 month | Net Cash Provided by (Used in) Operating Activities 107 month | Net Cash Provided by (Used in) Operating Activities 110 month | Net Cash Provided by (Used in) Operating Activities 113 month | Net Cash Provided by (Used in) Operating Activities 116 month | Net Cash Provided by (Used in) Operating Activities 119 month | Net Cash Provided by (Used in) Operating Activities 122 month | Net Cash Provided by (Used in) Operating Activities 125 month | Net Cash Provided by (Used in) Operating Activities 128 month | Net Cash Provided by (Used in) Operating Activities 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$10.86M 10-Q · filed 2026-08-13 | -$15.20M derived: sum of 3 quarters · filed 2026-08-13 | -$19.47M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2026-03-31 | -$4.85M 10-Q · filed 2026-05-14 | -$9.19M derived: sum of 2 quarters · filed 2026-05-14 | -$13.46M derived: sum of 3 quarters · filed 2026-05-14 | -$18.58M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-12-31 | -$4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$8.62M derived: sum of 2 quarters · filed 2026-03-04 | -$13.73M derived: sum of 3 quarters · filed 2026-08-13 | -$23.12M 10-K · filed 2026-03-04 | ||||||||||
| 2025-09-30 | -$4.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$9.39M derived: sum of 2 quarters · filed 2026-08-13 | -$18.77M 10-Q · filed 2025-11-13 | -$29.69M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-06-30 | -$5.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$14.50M 10-Q · filed 2026-08-13 | -$25.41M derived: sum of 3 quarters · filed 2026-08-13 | -$34.58M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-03-31 | -$9.38M 10-Q · filed 2026-05-14 | -$20.30M derived: sum of 2 quarters · filed 2026-05-14 | -$29.46M derived: sum of 3 quarters · filed 2026-05-14 | -$43.60M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||||
| 2024-12-31 | -$10.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$20.08M derived: sum of 2 quarters · filed 2026-03-04 | -$34.22M derived: sum of 3 quarters · filed 2026-03-04 | -$47.58M 10-K · filed 2026-03-04 | ||||||||||
| 2024-09-30 | -$9.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$23.31M derived: sum of 2 quarters · filed 2025-11-13 | -$36.67M 10-Q · filed 2025-11-13 | -$46.27M derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||
| 2024-06-30 | -$14.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$27.50M 10-Q · filed 2025-08-14 | -$37.10M derived: sum of 3 quarters · filed 2025-08-14 | -$45.17M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||
| 2024-03-31 | -$13.36M 10-Q · filed 2025-05-13 | -$22.96M derived: sum of 2 quarters · filed 2025-05-13 | -$31.03M derived: sum of 3 quarters · filed 2025-05-13 | -$38.55M derived: sum of 4 quarters · filed 2025-05-13 | ||||||||||
| 2023-12-31 | -$9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$17.66M derived: sum of 2 quarters · filed 2025-03-13 | -$25.19M derived: sum of 3 quarters · filed 2025-03-13 | -$32.38M 10-K · filed 2025-03-13 | ||||||||||
| 2023-09-30 | -$8.07M derived: 10-Q 9 month − 10-K/A 6 month · filed 2024-11-18 | -$15.60M derived: sum of 2 quarters · filed 2024-11-18 | -$22.78M 10-Q · filed 2024-11-18 | -$30.19M derived: sum of 4 quarters · filed 2024-11-18 | ||||||||||
| 2023-06-30 | -$7.53M derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-10-29 | -$14.71M 10-K/A · filed 2024-10-29 | -$22.13M derived: sum of 3 quarters · filed 2024-10-29 | -$29.14M derived: sum of 4 quarters · filed 2024-10-29 | ||||||||||
| 2023-03-31 | -$7.18M 10-K/A · filed 2024-10-29 | -$14.60M derived: sum of 2 quarters · filed 2024-10-29 | -$21.61M derived: sum of 3 quarters · filed 2024-10-29 | -$27.37M derived: sum of 4 quarters · filed 2024-10-29 | ||||||||||
| 2022-12-31 | -$7.41M derived: 10-K/A 12 month − 10-K/A 9 month · filed 2024-10-29 | -$14.42M derived: sum of 2 quarters · filed 2024-10-29 | -$20.18M derived: sum of 3 quarters · filed 2024-10-29 | -$25.22M 10-K/A · filed 2024-10-29 | ||||||||||
| 2022-09-30 | -$7.01M derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-10-29 | -$12.77M derived: sum of 2 quarters · filed 2024-10-29 | -$17.81M 10-K/A · filed 2024-10-29 | -$22.32M derived: sum of 4 quarters · filed 2024-10-29 | ||||||||||
| 2022-06-30 | -$5.76M derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-10-29 | -$10.80M 10-K/A · filed 2024-10-29 | -$15.31M derived: sum of 3 quarters · filed 2024-10-29 | -$21.74M derived: sum of 4 quarters · filed 2024-10-29 | ||||||||||
| 2022-03-31 | -$5.04M 10-K/A · filed 2024-10-29 | -$9.55M derived: sum of 2 quarters · filed 2024-10-29 | -$15.98M derived: sum of 3 quarters · filed 2024-10-29 | -$22.86M derived: sum of 4 quarters · filed 2024-10-29 | ||||||||||
| 2021-12-31 | -$4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$10.94M derived: sum of 2 quarters · filed 2023-03-09 | -$17.82M derived: sum of 3 quarters · filed 2023-03-09 | -$22.57M 10-K · filed 2023-03-09 | ||||||||||
| 2021-09-30 | -$6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$13.31M derived: sum of 2 quarters · filed 2022-11-03 | -$18.06M 10-Q · filed 2022-11-03 | -$21.93M derived: sum of 4 quarters · filed 2022-11-03 | ||||||||||
| 2021-06-30 | -$6.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$11.63M 10-Q · filed 2022-08-05 | -$15.50M derived: sum of 3 quarters · filed 2022-08-05 | -$19.00M derived: sum of 4 quarters · filed 2022-08-05 | ||||||||||
| 2021-03-31 | -$4.75M 10-Q · filed 2022-05-10 | -$8.62M derived: sum of 2 quarters · filed 2022-05-10 | -$12.12M derived: sum of 3 quarters · filed 2022-05-10 | -$15.17M derived: sum of 4 quarters · filed 2022-05-10 | ||||||||||
| 2020-12-31 | -$3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$7.37M derived: sum of 2 quarters · filed 2022-03-21 | -$10.42M derived: sum of 3 quarters · filed 2022-03-21 | -$13.93M 10-K · filed 2022-03-21 | ||||||||||
| 2020-09-30 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$6.55M derived: sum of 2 quarters · filed 2021-11-08 | -$10.06M 10-Q · filed 2021-11-08 | -$12.75M derived: sum of 4 quarters · filed 2021-11-08 | ||||||||||
| 2020-06-30 | -$3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$6.56M 10-Q · filed 2021-08-09 | -$9.24M derived: sum of 3 quarters · filed 2021-08-09 | -$12.79M derived: sum of 4 quarters · filed 2021-08-09 | ||||||||||
| 2020-03-31 | -$3.51M 10-Q · filed 2021-05-10 | -$6.19M derived: sum of 2 quarters · filed 2021-05-10 | -$9.74M derived: sum of 3 quarters · filed 2021-05-10 | -$12.39M derived: sum of 4 quarters · filed 2021-05-10 | ||||||||||
| 2019-12-31 | -$2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$6.23M derived: sum of 2 quarters · filed 2021-03-02 | -$8.88M derived: sum of 3 quarters · filed 2021-03-02 | -$11.69M 10-K · filed 2021-03-02 | ||||||||||
| 2019-09-30 | -$3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$6.20M derived: sum of 2 quarters · filed 2020-11-09 | -$9.01M 10-Q · filed 2020-11-09 | -$11.76M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||
| 2019-06-30 | -$2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$5.47M 10-Q · filed 2020-08-10 | -$8.21M derived: sum of 3 quarters · filed 2020-08-10 | -$11.18M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||
| 2019-03-31 | -$2.82M 10-Q · filed 2020-05-07 | -$5.56M derived: sum of 2 quarters · filed 2020-05-07 | -$8.53M derived: sum of 3 quarters · filed 2020-05-07 | -$11.07M derived: sum of 4 quarters · filed 2020-05-07 | ||||||||||
| 2018-12-31 | -$2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$5.71M derived: sum of 2 quarters · filed 2020-03-09 | -$8.26M derived: sum of 3 quarters · filed 2020-03-09 | -$11.44M 10-K · filed 2020-03-09 | ||||||||||
| 2018-09-30 | -$2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$5.51M derived: sum of 2 quarters · filed 2019-11-12 | -$8.70M 10-Q · filed 2019-11-12 | -$11.52M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||
| 2018-06-30 | -$2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$5.73M 10-Q · filed 2019-08-12 | -$8.56M derived: sum of 3 quarters · filed 2019-08-12 | -$11.10M derived: sum of 4 quarters · filed 2019-08-12 | ||||||||||
| 2018-03-31 | -$3.18M 10-Q · filed 2019-05-06 | -$6.01M derived: sum of 2 quarters · filed 2019-05-06 | -$8.55M derived: sum of 3 quarters · filed 2019-05-06 | -$11.22M derived: sum of 4 quarters · filed 2019-05-06 | ||||||||||
| 2017-12-31 | -$2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$5.37M derived: sum of 2 quarters · filed 2019-02-26 | -$8.03M derived: sum of 3 quarters · filed 2019-02-26 | -$11.02M 10-K · filed 2019-02-26 | ||||||||||
| 2017-09-30 | -$2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$5.21M derived: sum of 2 quarters · filed 2018-11-13 | -$8.19M 10-Q · filed 2018-11-13 | -$10.54M derived: sum of 4 quarters · filed 2018-11-13 | ||||||||||
| 2017-06-30 | -$2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$5.65M 10-Q · filed 2018-08-10 | -$8.00M derived: sum of 3 quarters · filed 2018-08-10 | |||||||||||
| 2017-03-31 | -$2.99M 10-Q · filed 2018-05-11 | -$5.34M derived: sum of 2 quarters · filed 2018-05-11 | ||||||||||||
| 2016-12-31 | -$2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | -$8.28M 10-K · filed 2018-03-21 | ||||||||||||
| 2016-09-30 | -$5.93M 10-Q · filed 2017-11-09 | |||||||||||||
| 2013-09-30 | -$2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$4.59M derived: sum of 2 quarters · filed 2013-11-13 | -$6.48M 10-Q · filed 2013-11-13 | -$8.17M derived: sum of 4 quarters · filed 2013-11-13 | -$38.19M 10-Q · filed 2013-11-13 | |||||||||
| 2013-06-30 | -$2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$3.92M 10-Q · filed 2013-08-12 | -$5.62M derived: sum of 3 quarters · filed 2013-08-12 | -$7.31M derived: sum of 4 quarters · filed 2013-11-13 | -$35.64M 10-Q · filed 2013-08-12 | |||||||||
| 2013-03-31 | -$1.89M 10-Q · filed 2013-05-15 | -$3.58M derived: sum of 2 quarters · filed 2013-05-15 | -$5.27M derived: sum of 3 quarters · filed 2013-11-13 | -$6.77M derived: sum of 4 quarters · filed 2013-11-13 | -$33.61M 10-Q · filed 2013-05-15 | |||||||||
| 2012-12-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$3.38M derived: sum of 2 quarters · filed 2013-11-13 | -$4.88M derived: sum of 3 quarters · filed 2013-11-13 | -$6.59M 10-K · filed 2013-03-28 | -$31.72M 10-K · filed 2013-03-28 | |||||||||
| 2012-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$3.19M derived: sum of 2 quarters · filed 2013-11-13 | -$4.89M 10-Q · filed 2013-11-13 | -$6.43M derived: sum of 4 quarters · filed 2013-11-13 | -$30.02M 10-Q · filed 2012-11-06 | |||||||||
| 2012-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$3.20M 10-Q · filed 2013-08-12 | -$4.74M derived: sum of 3 quarters · filed 2013-08-12 | -$6.27M derived: sum of 4 quarters · filed 2013-08-12 | -$28.33M 10-Q · filed 2012-08-09 | |||||||||
| 2012-03-31 | -$1.70M 10-Q · filed 2013-05-15 | -$3.24M derived: sum of 2 quarters · filed 2013-05-15 | -$4.77M derived: sum of 3 quarters · filed 2013-05-15 | -$7.35M derived: sum of 4 quarters · filed 2013-05-15 | -$26.84M 10-Q · filed 2012-05-04 | |||||||||
| 2011-12-31 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$3.07M derived: sum of 2 quarters · filed 2013-03-28 | -$5.65M derived: sum of 3 quarters · filed 2013-03-28 | -$5.97M 10-K · filed 2013-03-28 | -$25.13M 10-K · filed 2012-03-09 | |||||||||
| 2011-09-30 | -$1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$4.11M derived: sum of 2 quarters · filed 2012-11-06 | -$4.43M 10-Q · filed 2012-11-06 | -$4.55M derived: sum of 4 quarters · filed 2012-11-06 | -$23.60M 10-Q · filed 2011-11-07 | |||||||||
| 2011-06-30 | -$2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$2.90M 10-Q · filed 2012-08-09 | -$3.02M derived: sum of 3 quarters · filed 2012-08-09 | -$3.64M derived: sum of 4 quarters · filed 2012-08-09 | -$22.07M 10-Q · filed 2011-08-12 | |||||||||
| 2011-03-31 | -$324.57K 10-Q · filed 2012-05-04 | -$437.65K derived: sum of 2 quarters · filed 2012-05-04 | -$1.06M derived: sum of 3 quarters · filed 2012-05-04 | |||||||||||
| 2010-12-31 | -$113.08K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | -$736.62K derived: sum of 2 quarters · filed 2012-03-09 | -$3.38M 10-K · filed 2012-03-09 | |||||||||||
| 2010-09-30 | -$623.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$3.27M 10-Q · filed 2011-11-07 | ||||||||||||
| 2010-06-30 | -$2.65M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |